Physician profile
James Ferrell
NPI 1689673469
$2,853.48
in general payments reported to CMS, 2019-2025
13 companies · $342 in 2025
The $342 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $291 · 2020: $249 · 2021: $330 · 2022: $323 · 2023: $819 · 2024: $498 · 2025: $342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,659.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,295.34 | 2019-2025 | Precision 1, Total30, Dailies Total1 |
| Biotissue Holdings INC. | $429.23 | 2023-2025 | |
| Johnson & Johnson Vision Care, INC. | $304.01 | 2019-2025 | Acuvue |
| Sun Pharmaceutical Industries INC. | $264.45 | 2020-2025 | Cequa |
| Bausch & Lomb Americas INC. | $164.62 | 2023-2025 | Vyzulta, Miebo, Xiidra |
| Coopervision INC. | $110.95 | 2019 | |
| Aerie Pharmaceuticals, INC. | $100.53 | 2020 | |
| Allergan, INC. | $42.63 | 2020-2021 | |
| Glaukos Corporation | $39.77 | 2024 | Radius |
| Tarsus Pharmaceuticals, INC. | $37.39 | 2025 | Xdemvy |
| Oyster Point Pharma, INC. | $25.69 | 2024 | Tyrvaya |
| Novartis Pharmaceuticals Corporation | $22.67 | 2019 | |
| Xeris Pharmaceuticals, INC. | $16.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Ferrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.